Results 251 to 260 of about 176,842 (290)
Some of the next articles are maybe not open access.

Related searches:

Lean/normal‐weight metabolic dysfunction‐associated fatty liver disease is a risk factor for reflux esophagitis

Hepatology Research, 2022
Reflux esophagitis is associated with metabolic dysfunction. Recently, fatty liver has been redefined as metabolic dysfunction‐associated fatty liver disease (MAFLD).
S. Fukunaga   +11 more
semanticscholar   +1 more source

Ambulatory pH-Impedance Findings Confirm That Grade B Esophagitis Provides Objective Diagnosis of Gastroesophageal Reflux Disease

American Journal of Gastroenterology, 2022
INTRODUCTION: The Lyon Consensus designates Los Angeles (LA) grade C/D esophagitis or acid exposure time (AET) >6% on impedance-pH monitoring (MII-pH) as conclusive for gastroesophageal reflux disease (GERD).
Pierfrancesco Visaggi   +12 more
semanticscholar   +1 more source

Role of Reflux in the Pathogenesis of Eosinophilic Esophagitis: Comprehensive Appraisal With Off- and On PPI Impedance-pH Monitoring.

American Journal of Gastroenterology, 2019
OBJECTIVES Role of reflux and mechanisms of response to proton pump inhibitor (PPI) therapy in eosinophilic esophagitis (EoE) have not yet been fully elucidated. Comprehensive assessment by impedance-pH monitoring could clarify these issues.
M. Frazzoni   +11 more
semanticscholar   +1 more source

Gastroesophageal Reflux Disease: A Review.

Journal of the American Medical Association (JAMA), 2020
Importance Gastroesophageal reflux disease (GERD) is defined by recurrent and troublesome heartburn and regurgitation or GERD-specific complications and affects approximately 20% of the adult population in high-income countries.
J. Maret-Ouda, S. Markar, J. Lagergren
semanticscholar   +1 more source

Saliva secretion is reduced in mild reflux esophagitis patients

Esophagus, 2021
Mai Koeda   +8 more
semanticscholar   +1 more source

Efficacy of long-term maintenance therapy with 10-mg vonoprazan for proton pump inhibitor-resistant reflux esophagitis

Esophagus, 2019
Tomohide Tanabe   +8 more
semanticscholar   +1 more source

Efficacy of Vonoprazan for Proton Pump Inhibitor-Resistant Reflux Esophagitis

Digestion, 2017
Shintaro Hoshino   +10 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy